Search Results 151-160 of 15515 for B%20cell%20lymphomas

  1. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

    Part 1 is a dose escalation phase to determine the maximum tolerated dose (MTD) of INCB040093, a PI3Kδ inhibitor, or a tolerated, pharmacologically active dose; ...

  2. Moain Abu Dabrh, M.B., B.Ch., M.S. - Mayo Clinic Faculty Profiles

    Learn more about the research interests of Abd Moain (Moain) Abu Dabrh, M.B., B.Ch.

  3. Acute lymphocytic leukemia - Symptoms and causes - Mayo Clinic

    Learn about this cancer that forms in the blood and bone marrow. Treatments include medications and bone marrow transplant.

  4. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma · Share ...

  5. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Patients to be included in Cohorts 1 and 4, and who have received rituximab or other B cell ablation therapy within 8 weeks of start of study treatment. 7 ...

  6. Chronic lymphocytic leukemia - Diagnosis and treatment - Mayo Clinic

    A complete blood count may be used to count the number of lymphocytes in a blood sample. A high number of B cells, one type of lymphocyte, may indicate chronic ...

  7. Mayo Clinic Comprehensive Cancer Center — Research

    Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma.

  8. Lewis R. Roberts, M.B., Ch.B., Ph.D.

    B., Ph.D., is to understand the mechanisms by which liver and biliary cancers develop, grow and spread. Dr. Roberts' laboratory is particularly interested in ...

  9. Primary CNS Lymphoma Clinical Trials - Mayo Clinic Research

    Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. ... Pomalidomide may stimulate the immune system to kill cancer cells. Drugs used in ...

  10. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

    Clinical Trials · Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) · More about research at ...